Study Stopped
Funding shortage
Impact of Medical Follow-up Discharge Package
RECALL-CT
A Randomised Controlled Trial of an Integrated Post-discharge Transitional Care Package for General Medical In-patients in Cape Town, South Africa
1 other identifier
interventional
N/A
1 country
2
Brief Summary
The post discharge time is a vulnerable time for general medical in-patients, with high rates of adverse events that may cause unnecessary readmissions and even death. A recent study of 415 patients discharged from the general medical wards at Groote Schuur Hospital, demonstrated a very high 12 month mortality of 35%. The majority of these deaths were classified as "unexpected". The reasons for this were not further examined, but it was speculated, given the authors' knowledge of the public sector in Cape Town, that three related factors contribute significantly to this early mortality: i) a lack of continuity of care, with patients not necessarily accessing the primary care support treatment that they need or being able to access early post discharge follow-up (for example for anti-retroviral or anti-tuberculous care); ii) the inability of primary care to deal with the complex nature of the discharged patients, most whom have significant co-morbid disease; iii) A lack of optimisation of therapy for chronic disease after acute discharge. The investigators hypothesise that an integrated post-discharge transitional care package, which includes an early medical specialist follow-up in the first 3 months after hospital discharge will decrease the 6- and 12-month mortality and re-admission rate amongst general medical hospital admissions in Cape Town, South Africa. Our study will compare an integrated package, suitable to implementation if effective, with current standard discharge packages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2015
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2013
CompletedFirst Posted
Study publicly available on registry
August 6, 2013
CompletedStudy Start
First participant enrolled
March 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedDecember 3, 2014
December 1, 2014
9 months
August 1, 2013
December 2, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All cause mortality
All cause 12-month mortality will be evaluated at 12-months post enrolment. Data on mortality will be acquired through telephonic patient/family contact and review of provincial death registry
12 months
Secondary Outcomes (4)
All cause mortality
6 months
Hospital readmission rate
12 months
Bartel index
12 months
Karnofsky performance score
12 months
Study Arms (2)
Standard Care
NO INTERVENTIONAt discharge, patients will be given a discharge plan by their attending caregiver as deemed appropriate.
Integrative medical follow-up package
OTHERAt discharge, patients will receive a discharge plan by their attending caregiver. Thereafter, if randomised to this study arm they will receive the intervention as outlined elsewhere. "Integrated Medical Follow-up package"
Interventions
At discharge, patients will receive a discharge plan by their attending caregiver. 1. On day 3 they will be contacted telephonically to: i) Discuss their discharge diagnosis and medications ii) Arrange specialist clinic follow-up booking for 2 weeks iii) Reemphasise drug compliance 2. Reminders via SMS to attend there OPD appointment(s) 3. Medical out-patient review at 2-weeks and 6 weeks if required 4. Medical telephonic "hot-line" for advice
Eligibility Criteria
You may qualify if:
- Patients referred for admission to general medical wards (including within hospital transfer e.g. ICU discharge)
- \>18 years and willing to give informed consent
You may not qualify if:
- Patient admitted directly to intensive care unit
- Patient refusing consent or \<18 years old
- Patients electively admitted
- Patients without phone numbers who cannot provide any telephone contact details for a co-habitant, relative or neighbour.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Groote Schuur Hospital
Cape Town, 8001, South Africa
Victoria Hospital
Cape Town, 8001, South Africa
Related Publications (1)
Stuart-Clark H, Vorajee N, Zuma S, Van Niekerk L, Burch V, Raubenheimer P, Peter JG. Twelve-month outcomes of patients admitted to the acute general medical service at Groote Schuur Hospital. S Afr Med J. 2012 May 23;102(6):549-53. doi: 10.7196/samj.5615.
PMID: 22668961BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Peter
University of Cape Town
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Honorary Consultant, Department of Medicine
Study Record Dates
First Submitted
August 1, 2013
First Posted
August 6, 2013
Study Start
March 1, 2015
Primary Completion
December 1, 2015
Study Completion
May 1, 2016
Last Updated
December 3, 2014
Record last verified: 2014-12